Duration of neurofibrillary changes in the hippocampal pyramidal neurons

Brain Research

Volumn 799, Issue 1, 1998, Pages 156-158

  Bobinski, Maciej ^a   Wegiel, Jerzy ^a   Tarnawski, Michal ^a   Bobinski, Margaret ^a   De Leon, Mony J ^b   Reisberg, Barry ^b   Miller, Douglas C ^b   Wisniewski, Henryk M ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Hippocampus; Neurofibrillary pathology; Neurofibrillary staging; Stereology

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DENTATE GYRUS; HUMAN; MORPHOMETRICS; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; SUBICULUM;

AGED; ALZHEIMER DISEASE; CADAVER; CELL COUNT; HIPPOCAMPUS; HUMANS; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PYRAMIDAL CELLS; TIME FACTORS;

EID: 0032514269     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00441-7     Document Type: Article

References (21)

1. Ball M.J. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. Acta Neuropathol. (Berl.). 37:1977;111-118.
2. Ball M.J. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of ageing and demented patients. Interdiscipl. Topics Gerontol. 25:1988;16-37.
3. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seitelberger F., Grundke-Iqbal I., Iqbal K., Wisniewski H.M. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:1989;90-99.
4. Bobinski M., Wegiel J., Wisniewski H.M., Tarnawski M., Reisberg B., Mlodzik B., De Leon M.J., Miller D.C. Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia. 6:1995;205-210.
5. Bobinski M.J., Wegiel J., Wisniewski H.M., Tarnawski M., Bobinski M., Reisberg B., De Leon M.J., Miller D.C. Neurofibrillary pathology - correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol. Aging. 17:1996;909-919.
6. Bobinski M.J., Wegiel J., Tarnawski M., Bobinski M., Reisberg B., De Leon M.J., Miller D.C., Wisniewski H.M. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1997;414-420.
7. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta. Neuropathol. 82:1991;239-259.
8. De Leon M.J., George A.E., Stylopoulos L.A., Smith G., Miller D.C. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet. 2:1989;672-673.
9. De Leon M.J., Golomb J., George A.E., Convit A., Tarshish C.Y., McRae T., De Santi S., Smith G., Ferris S.H., Noz M. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR. 14:1993;897-906.
10. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
11. Grundke-Iqbal I., Iqbal K., Tung Y.-C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA. 83:1986;4913-4917.
12. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1170.
13. Hyman B.T., Van Hoesen G.W., Damasio A.R. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology. 40:1990;1721-1730.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D.L., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
15. Mirra S.S., Noel Hart M., Terry R.D. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch. Pathol. Lab. Med. 117:1993;132-144.
16. Ohm T.G., Müller H., Braak H., Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience. 64:1995;209-217.
17. Perry G., Mulvihill P., Manetto V., Fried V., Smith H., Grundke-Iqbal I., Iqbal K., Autilio-Gambetti L., Gambetti P. Ubiquitin epitopes in Alzheimer paired helical filaments: a study with monoclonal antibodies to ubiquitin and paired helical filaments. J. Cell Biol. 105:1987;203a.
18. Wang G.P., Grundke-Iqbal I., Kascsak R.J., Iqbal K., Wisniewski H.M. Alzheimer neurofibrillary tangles: monoclonal antibodies to inherent antigen(s). Acta. Neuropathol. 62:1984;268-275.
19. West M.J., Gundersen H.J.G. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. Comp. Neurol. 296:1990;1-22.
20. Wisniewski T., Dowjat W.T., Buxbaum J.D., Khorkova O., Efthimiopoulos S., Kulczycki J., Lojkowska W., Wegiel J., Wisniewski H.M., Frangione B. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. NeuroReport. 9:1998;217-221.
21. Yamaguchi H., Morimatsu M., Hirai S., Takahashi K. Alzheimer's neurofibrillary tangles are penetrated by astroglial processes and appear eosinophilic in their final stages. Acta. Neuropathol. (Berl.). 72:1987;214-217.